Class 1, 2 and 3 integrons in clinical Pseudomonas aeruginosa isolated from Tanta University Hospitals, Egypt

References

• Akrami F, Rajabnia M, Pournajaf A. Resistance integrons; a mini review. Caspian J Intern Med. 2019;10(4):370–376.
   PubMed Web of Science ®Google Scholar
• Domingues S, da Silva GJ, Nielsen KM. Integrons: vehicles and pathways for horizontal dissemination in bacteria. Mob Genet Elements. 2012;2(5):211–223.
   PubMedGoogle Scholar
• Fluit AC, Schmitz FJ. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur J Clin Microbiol Infect Dis. 1999;18(11):761–770.
   PubMed Web of Science ®Google Scholar
• Mathai E, Grape M, Kronvall G. Integrons and multidrug resistance among Escherichia coli causing community-acquired urinary tract infection in Southern India. APMIS. 2004;112(3):159–164.
   PubMed Web of Science ®Google Scholar
• Mazel D, Dychinco B, Webb VA, et al. Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob Agents Chemother. 2000;44(6):1568–1574.
   PubMed Web of Science ®Google Scholar
• Brown HJ, Stokes HW, Hall RM. The integrons In0, In2, and In5 are defective transposon derivatives. J Bacteriol. 1996;178(15):4429–4437.
   PubMed Web of Science ®Google Scholar
• Hall RM, Collis CM. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol Microbiol. 1995;15(4):593–600.
   PubMed Web of Science ®Google Scholar
• Stokes HW, Hall RM. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol Microbiol. 1989;3(12):1669–1683.
   PubMed Web of Science ®Google Scholar
• Partridge SR, Tsafnat G, Coiera E, et al. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol Rev. 2009;33(4):757–784.
   PubMed Web of Science ®Google Scholar
• Fluit AC, Schmitz FJ. Resistance integrons and super-integrons. Clin Microbiol Infect. 2004;10(4):272–288.
   PubMed Web of Science ®Google Scholar
• Shi L, Zheng M, Xiao Z, et al. Unnoticed spread of class 1 integrons in gram-positive clinical strains isolated in Guangzhou, China. Microbiol Immunol. 2006;50(6):463–467.
   PubMed Web of Science ®Google Scholar
• Nesvera J, Hochmannová J, Pátek M. An integron of class 1 is present on the plasmid pCG4 from gram-positive bacterium Corynebacterium glutamicum. FEMS Microbiol Lett. 1998;169(2):391–395.
   PubMed Web of Science ®Google Scholar
• Correia M, Boavida F, Grosso F, et al. Molecular characterization of a new class 3 integron in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2003;47(9):2838–2843.
   PubMed Web of Science ®Google Scholar
• Machado E, Cantón R, Baquero F, et al. Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother. 2005;49(5):1823–1829.
   PubMed Web of Science ®Google Scholar
• Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48(suppl 1):5–16.
   PubMed Web of Science ®Google Scholar
• CLSI. Standards for antimicrobial susceptibility testing. 31st ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2021.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
   PubMed Web of Science ®Google Scholar
• Mobaraki S, Aghazadeh M, Barhaghi MHS, et al. Prevalence of integrons 1, 2, 3 associated with antibiotic resistance in Pseudomonas aeruginosa isolates from northwest of Iran. Biomedicine (Taipei). 2018;8(1):2.
   PubMedGoogle Scholar
• Raman G, Avendano E, Chan J, et al. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and Meta-analysis. Antimicrob Resist Infect Control. 2018;7:79.
   PubMed Web of Science ®Google Scholar
• Sid Ahmed MA, Hassan AAI, Abu Jarir S, et al. Emergence of multidrug- and pandrug- resistant Pseudomonas aeruginosa from five hospitals in Qatar. Infect Prev Pract. 2019;1(3–4):100027.
   PubMedGoogle Scholar
• Mirzaei B, Bazgir ZN, Goli HR, et al. Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran. BMC Res Notes. 2020;13(1):380.
   PubMedGoogle Scholar
• Saleem S, Bokhari H. Resistance profile of genetically distinct clinical Pseudomonas aeruginosa isolates from public hospitals in Central Pakistan. J Infect Public Health. 2020;13(4):598–605.
   PubMed Web of Science ®Google Scholar
• Abd El-Baky RM, Masoud SM, Mohamed DS, et al. Prevalence and some possible mechanisms of colistin resistance among multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa. Infect Drug Resist. 2020;13:323–332.
   PubMed Web of Science ®Google Scholar
• Bahey MG, El-Enany AE, Abd El-Hamid MI, et al. In vitro study on the efficacy of silver nanoparticles against metallo-beta-lactamase and biofilm producing Pseudomonas aeruginosa isolates. Int J Curr Microbiol Appl Sci. 2019;8(06):2931–2948.
   Google Scholar
• Pungcharoenkijkul S, Traipattanakul J, Thunyaharn S, et al. Antimicrobials as single and combination therapy for colistin-resistant Pseudomonas aeruginosa at a university hospital in Thailand. Antibiotics (Basel). 2020;9(8):475.
   Web of Science ®Google Scholar
• Nikokar I, Tishayar A, Flakiyan Z, et al. Antibiotic resistance and frequency of class 1 integrons among Pseudomonas aeruginosa, isolated from burn patients in Guilan, Iran. Iran J Microbiol. 2013;5(1):36–41.
   PubMedGoogle Scholar
• Xu Z, Li L, Shirtliff ME, et al. Occurrence and characteristics of class 1 and 2 integrons in Pseudomonas aeruginosa isolates from patients in Southern China. J Clin Microbiol. 2009;47(1):230–234.
   PubMed Web of Science ®Google Scholar
• Faghri J, Nouri S, Jalalifar S, et al. Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran. BMC Res Notes. 2018;11(1):806.
   PubMedGoogle Scholar
• Khosravi AD, Motahar M, Abbasi Montazeri E. The frequency of class1 and 2 integrons in Pseudomonas aeruginosa strains isolated from burn patients in a burn center of Ahvaz, Iran. PLoS One. 2017;12(8):e0183061.
   PubMed Web of Science ®Google Scholar
• Poonsuk K, Tribuddharat C, Chuanchuen R. Class 1 integrons in Pseudomonas aeruginosa and Acinetobacter baumannii isolated from clinical isolates. Southeast Asian J Trop Med Public Health. 2012;43(2):376–384.
   PubMed Web of Science ®Google Scholar
• Fonseca EL, Vieira VV, Cipriano R, et al. Class 1 integrons in Pseudomonas aeruginosa isolates from clinical settings in Amazon region, Brazil. FEMS Immunol Med Microbiol. 2005;44(3):303–309.
   PubMedGoogle Scholar
• Hsueh PR, Teng LJ, Yang PC, et al. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J Clin Microbiol. 1998;36(5):1347–1351.
   PubMed Web of Science ®Google Scholar
• Gu B, Tong M, Zhao W, et al. Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J Clin Microbiol. 2007;45(1):241–243.
   PubMed Web of Science ®Google Scholar